Bill > A07550

This bill adds tianeptine sodium, a drug with potential for abuse, to Schedule II of controlled substances in New York. Schedule II substances have accepted medical uses but also a high potential for abuse, making them subject to stricter regulation. The bill aims to address the rising concerns around the misuse of tianeptine sodium by reclassifying it as a more tightly controlled substance. This change will impact how tianeptine sodium can be prescribed, distributed, and accessed within the state.